Physician

Anand Patel, MD

According to 2025 Medicare claims, Anand Patel, MD (NPI: 1669911863) practices rheumatology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is PRINCETON MEDICAL GROUP,P.A. (NPI: 1063513679; TIN: 222306123) and primary practice location at 08536-1913. Patel is affiliated with the Aledade 25 NJ MSSP Enhanced (ACO ID: A3891), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 432 traditional Medicare patients, billed 61,661 HCPCS/CPT codes, and received $976,341 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,255 prescription claims across 265 beneficiaries totaling $1,601,118 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 17 records totaling $166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $50,947 to $976,341. Similarly, Part D prescription costs have moved sharply higher in recent years, from $147,033 to $1,601,118. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$488K$976K2019 Medicare payment: $50,947 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $195,545 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $368,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $533,965 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $871,461 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $976,341 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019791,147$50,947
202019013,856$195,545
202134123,936$368,444
202236840,318$533,965
202347261,449$871,461
202443261,661$976,341

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$801K$1.6M2018 Drug cost: $147,033 (USD; Tot_Drug_Cst)2019 Drug cost: $106,106 (USD; Tot_Drug_Cst)2020 Drug cost: $152,252 (USD; Tot_Drug_Cst)2021 Drug cost: $476,751 (USD; Tot_Drug_Cst)2022 Drug cost: $642,913 (USD; Tot_Drug_Cst)2023 Drug cost: $1,188,868 (USD; Tot_Drug_Cst)2024 Drug cost: $1,601,118 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201857278$147,033
201995466$106,106
2020126479$152,252
2021219850$476,751
20222581,074$642,913
20232831,210$1,188,868
20242651,255$1,601,118

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more356731$101
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's254443$14
80053Blood test, comprehensive group of blood chemicals194362$10
36415Insertion of needle into vein for collection of blood sample235426$9
85651Red blood cell sedimentation rate, to detect inflammation, non-automated149285$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab661,848$536,917
Humira PenAdalimumab331,204$365,339
Enbrel SureclickEtanercept27756$196,094
Actemra ActpenTocilizumab411,428$160,008
EnbrelEtanercept13364$93,577

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$166Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anand Patel, MD?

Tedicare shows public-source Medicare data for Anand Patel, MD (NPI 1669911863), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anand Patel, MD have ACO affiliation data?

Anand Patel, MD is shown with ACO affiliation data for Aledade 25 NJ MSSP Enhanced (MSSP, ACO ID A3891).

What billing organization is linked to Anand Patel, MD?

Anand Patel, MD is linked to PRINCETON MEDICAL GROUP,P.A. (billing NPI 1063513679) in the available physician profile data.

Does Anand Patel, MD have Open Payments data?

Anand Patel, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.